ARVN Q2 2018 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+103.7% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$9M-250.5% margin

Net Income

-$8M-231.0% margin

EPS (Diluted)

$-0.73

QoQ Revenue Growth

-17.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$979,873

Balance Sheet

Total Assets

$106M

Total Liabilities

$62M

Stockholders' Equity

$44M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+103.7%
Gross Profit	$3M	$2M	+103.7%
Operating Income	-$9M	-$7M	-26.7%
Net Income	-$8M	-$7M	-17.6%